WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003002601) AFX$g(z) TRANSCRIPTION FACTOR SPLICE FORM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/002601    International Application No.:    PCT/EP2002/007160
Publication Date: 09.01.2003 International Filing Date: 28.06.2002
Chapter 2 Demand Filed:    17.01.2003    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35, CH-4056 Basel (CH) (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GB, GD, GE, GH, GR, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MC, MD, MK, MN, MX, NL, NO, NZ, OM, PH, PL, PT, RO, RU, SE, SG, SI, SK, TJ, TM, TN, TR, TT, UA, UZ, VN, YU, ZA, ZW only).
NOVARTIS PHARMA GMBH [AT/AT]; Brunner Strasse 59, A-1230 Vienna (AT) (AT only).
BOWEN, Benjamin, Robert [US/US]; (US) (For US Only).
YANG, Zhenyu [CN/US]; (US) (For US Only).
WHELAN, James, Patrick [IE/US]; (US) (For US Only)
Inventors: BOWEN, Benjamin, Robert; (US).
YANG, Zhenyu; (US).
WHELAN, James, Patrick; (US)
Agent: GROS, Florent; Novartis AG, Corporate Intellectual Property, Patent & Trademark Department, CH-4002 Basel (CH)
Priority Data:
60/302,134 29.06.2001 US
Title (EN) AFX$g(z) TRANSCRIPTION FACTOR SPLICE FORM
(FR) FORME EPISSEE DU FACTEUR DE TRANSCRIPTION AFX$G(Z)
Abstract: front page image
(EN)The subject invention is related to human AFX$g(z) genes and gene products methods of identifying substances which agonize or antagonize the AFX$g(z) gene or the AFX$g(z) gene product or AFX$g(z) regulated genes. Another aspect of the present invention concerns pharmaceutical compositions comprising such substances for the treatment of diseases related to AFX$g(z).
(FR)Gènes AFX$g(z) humains, produits géniques et procédés d'identification de substances qui sont des agonistes ou des antagonistes du gène AFX$g(z) ou du produit génique AFX$g(z) ou des gènes régulés par AXF$g(j). Un autre aspect de la présente invention concerne des compositions pharmaceutiques contenant des substances de ce type pour le traitement de maladies associées à AFX$g(z).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MD, MK, MN, MX, NO, NZ, OM, PH, PL, PT, RO, RU, SE, SG, SI, SK, TJ, TM, TN, TR, TT, UA, US, UZ, VN, YU, ZA, ZW.
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR).
Publication Language: English (EN)
Filing Language: English (EN)